Results 11 to 20 of about 99,632 (265)

Fishing for neuroendocrine tumors [PDF]

Endocrine-Related Cancer, 2020
Neuroendocrine tumors (NETs) are a class of rare and heterogeneous neoplasms that originate from the neuroendocrine system. In several cases, these neoplasms can release bioactive hormones leading to characteristic clinical syndromes and hormonal dysregulations with detrimental impact on the quality of life and survival of these patients.
Gaudenzi G., Carra S., Dicitore A., Cantone M. C., Persani L., Vitale G.   +5 more
openaire   +2 more sources

The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK

BMC Gastroenterology, 2020
Background NETest, a novel multi-gene liquid biopsy has utility in neuroendocrine tumor (NET) diagnosis and identification of residual disease. We independently assessed utility of the NETest to diagnose gastric neuroendocrine neoplasms (GNENs) and ...
A. Malczewska, A. Procner, A. Walter, K. Kusnierz, W. Zajecki, H. Aslanian, B. Kos-Kudla   +6 more
doaj   +1 more source

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance

Endocrine Connections, 2022
Objective: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied.
Mark J C van Treijen, Catharina M Korse, Wieke H Verbeek, Margot E T Tesselaar, Gerlof D Valk   +4 more
doaj   +1 more source

The influence of surgery quality on the longtime results of gastric cancer combination therapy

Nowotwory, 2022
INTRODUCTION: The aim of this study was to analyze the influence of surgical center experience on the long term survival of patients with locoregionally advanced gastric adenocarcinoma undergoing primary surgery, followed by comple­mentary ...
Ireneusz Pierzankowski, Adam Dmitruk, Sebastian Rybski, Lucjan Wyrwicz, Tomasz Olesiński   +4 more
doaj   +1 more source

Risk of malignancy in adrenal tumors in patients with a history of cancer

Frontiers in Oncology, 2023
PurposeAdrenal gland is a common site of metastasis and on the other hand, metastases are the most frequent malignant adrenal tumors. The aim of this study was to estimate the risk of malignancy in suspicious adrenal mass in patients with a history of ...
Radosław Samsel, Karolina Nowak, Lucyna Papierska, Edyta Karpeta, Edyta Karpeta, Katarzyna Roszkowska-Purska, Wacław Smiertka, Tomasz Ostrowski, Eryk Chrapowicki, Alan Grabowski, Dorota Leszczyńska, Andrzej Cichocki   +11 more
doaj   +1 more source

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease

BMC Cancer, 2020
Background There are several treatment modalities for unresectable neuroendocrine tumors. Traditionally, the aim of these treatments has been to reduce the tumor load; referred to as objective response (OR).
Espen Thiis-Evensen, Amalie Christine Poole, Hong-Thien Thi Nguyen, Jon Sponheim   +3 more
doaj   +1 more source

Updates on medical treatment for neuroendocrine neoplasm [PDF]

Zhongguo aizheng zazhi, 2022
Neuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine ...
LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie
doaj   +1 more source

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival

Frontiers in Endocrinology, 2022
BackgroundTumor grade determined by the Ki67 index is the best prognostic factor for pancreatic neuroendocrine tumors (PanNETs). However, we often observe that the grade of metastases differs from that of their primary tumors.
Wu-Hu Zhang, Wu-Hu Zhang, Wu-Hu Zhang, Wu-Hu Zhang, Wu-Hu Zhang, He-Li Gao, He-Li Gao, He-Li Gao, He-Li Gao, He-Li Gao, Wen-Sheng Liu, Wen-Sheng Liu, Wen-Sheng Liu, Wen-Sheng Liu, Wen-Sheng Liu, Yi Qin, Yi Qin, Yi Qin, Yi Qin, Yi Qin, Zeng Ye, Zeng Ye, Zeng Ye, Zeng Ye, Zeng Ye, Xin Lou, Xin Lou, Xin Lou, Xin Lou, Xin Lou, Fei Wang, Fei Wang, Fei Wang, Fei Wang, Fei Wang, Yue Zhang, Xue-Min Chen, Jie Chen, Jie Chen, Jie Chen, Jie Chen, Xian-Jun Yu, Xian-Jun Yu, Xian-Jun Yu, Xian-Jun Yu, Xian-Jun Yu, Qi-Feng Zhuo, Qi-Feng Zhuo, Qi-Feng Zhuo, Qi-Feng Zhuo, Qi-Feng Zhuo, Xiao-Wu Xu, Xiao-Wu Xu, Xiao-Wu Xu, Xiao-Wu Xu, Xiao-Wu Xu, Shun-Rong Ji, Shun-Rong Ji, Shun-Rong Ji, Shun-Rong Ji, Shun-Rong Ji   +60 more
doaj   +1 more source

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management

Pharmaceuticals, 2021
The carcinoid syndrome (CS) and hyperinsulinemic hypoglycemia (HH) represent two of the most common clinical syndromes associated with neuroendocrine neoplasms (NENs).
Francesca Spada, Roberta E. Rossi, Elda Kara, Alice Laffi, Sara Massironi, Manila Rubino, Franco Grimaldi, Sherrie Bhoori, Nicola Fazio   +8 more
doaj   +1 more source

Updates on precision medicine of pancreatic neuroendocrine tumor [PDF]

Zhongguo aizheng zazhi, 2023
Since the concept of precision medicine proposed in 2011, the treatment of solid tumors has entered era of precision medicine led by gene testing. As a rare tumor, the incidence rate of pancreatic neuroendocrine tumor (PanNET) is increasing gradually. In
GAO Heli, XU Jin, CHEN Jie, YU Xianjun
doaj   +1 more source